Geneos Wealth Management Inc. Dynavax Technologies Corp Transaction History

Geneos Wealth Management Inc.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 22, 2022	SELL	$7.45 - $12.83 $1,490 - $2,566	-200 Reduced 40.4%	295 $3,000
Q2 2021 Jul 08, 2021	SELL	$7.25 - $10.99 $290 - $439	-40 Reduced 7.48%	495 $4,000
Q4 2020 May 19, 2021	BUY	$3.73 - $5.6 $522 - $784	140 Added 35.44%	535 $5,000
Q3 2020 Sep 07, 2021	BUY	$4.32 - $11.7 $432 - $1,170	100 Added 33.9%	395 $1,000
Q3 2017 Sep 07, 2021	BUY	$15.2 - $21.5 $1,520 - $2,150	100 Added 51.28%	295 $6,000
Q1 2017 Sep 07, 2021	BUY	N/A	195 New	195 $1,000
Q4 2016 Sep 07, 2021	SELL	N/A	-195 Closed	0 $0
Q1 2016 Sep 07, 2021	BUY	N/A	195	195 $3,000

275

130M

451K

203K

Ticker DVAX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 126,474,000
Market Cap $1.63B
Description
Dynavax Technologies Corporation, a biopharmaceutical company, focuses on developing and commercializing novel vaccines in the United States. The company markets HEPLISAV-B, a hepatitis B vaccine for prevention of infection caused by all known subtypes of hepatitis B virus in age 18 years and older in the United States and Europe. It also manufa...

Get notified when there are updates to the investment portfolio of Geneos Wealth Management Inc., based on Form 13F filings with the SEC.

Stay updated on Geneos Wealth Management Inc. with notifications on news.